Autolus Therapeutics (AUTL) Free Cash Flow (2017 - 2025)
Autolus Therapeutics posted quarterly Free Cash Flow of -$48.6 million for Q4 2025, down 68.81% year-on-year from -$155.7 million in Q4 2024, and up 32.85% on a QoQ basis from -$72.3 million in Q3 2025.
Autolus Therapeutics (AUTL) has 9 years of Free Cash Flow data on file, last reported at -$48.6 million in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow fell 68.81% year-over-year to -$48.6 million; the trailing twelve-month figure through Dec 2025 stood at -$284.7 million (down 36.85% YoY), and the FY2025 full-year result was -$284.7 million, down 36.85% from the prior year.
- Free Cash Flow for Q4 2025 stood at -$48.6 million, up from -$72.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$24.2 million in Q4 2022 and bottomed at -$86.3 million in Q3 2024.
- The 5-year median for Free Cash Flow is -$36.6 million (2022), against an average of -$45.0 million.
- The widest annual swing landed in 2021, when Free Cash Flow soared 51.01%; it then tumbled 104.07% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$25.3 million in 2021, then gained by 4.35% to -$24.2 million in 2022, then declined by 8.77% to -$26.3 million in 2023, then decreased by 9.33% to -$28.8 million in 2024, then tumbled by 68.81% to -$48.6 million in 2025.
- The last three Free Cash Flow figures came in at -$48.6 million (Q4 2025), -$72.3 million (Q3 2025), and -$80.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 848.30 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | -48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -48.56 Mn |
| Dec 31, 2025 | -48.56 Mn |
| Sep 30, 2025 | -72.31 Mn |
| Sep 30, 2025 | -72.31 Mn |
| Jun 30, 2025 | -80.06 Mn |
| Jun 30, 2025 | -80.06 Mn |
| Mar 31, 2025 | -83.81 Mn |
| Mar 31, 2025 | -83.81 Mn |
| Dec 31, 2024 | -28.76 Mn |
| Dec 31, 2024 | -28.76 Mn |
| Sep 30, 2024 | -86.33 Mn |
| Sep 30, 2024 | -86.33 Mn |
| Jun 30, 2024 | -51.90 Mn |
| Jun 30, 2024 | -51.90 Mn |
| Mar 31, 2024 | -41.07 Mn |
| Mar 31, 2024 | -41.07 Mn |
| Dec 31, 2023 | -26.31 Mn |
| Dec 31, 2023 | -26.31 Mn |
| Sep 30, 2023 | -47.44 Mn |
| Sep 30, 2023 | -47.44 Mn |
| Jun 30, 2023 | -36.72 Mn |
| Jun 30, 2023 | -36.72 Mn |
| Mar 31, 2023 | -46.11 Mn |
| Mar 31, 2023 | -46.11 Mn |
| Dec 31, 2022 | -24.19 Mn |
| Dec 31, 2022 | -24.19 Mn |
| Sep 30, 2022 | -36.53 Mn |
| Sep 30, 2022 | -36.53 Mn |
| Jun 30, 2022 | -28.17 Mn |
| Jun 30, 2022 | -28.17 Mn |
| Mar 31, 2022 | -34.26 Mn |
| Mar 31, 2022 | -34.26 Mn |
| Dec 31, 2021 | -25.29 Mn |
| Dec 31, 2021 | -25.29 Mn |
| Sep 30, 2021 | -30.89 Mn |
| Sep 30, 2021 | -30.89 Mn |
| Jun 30, 2021 | -35.10 Mn |
| Jun 30, 2021 | -35.10 Mn |
| Mar 31, 2021 | -35.44 Mn |
| Mar 31, 2021 | -35.44 Mn |
| Dec 31, 2020 | -51.62 Mn |
| Dec 31, 2020 | -51.62 Mn |
| Sep 30, 2020 | -35.01 Mn |
| Sep 30, 2020 | -35.01 Mn |
| Jun 30, 2020 | -24.41 Mn |
| Jun 30, 2020 | -24.41 Mn |
| Mar 31, 2020 | -21.40 Mn |
| Mar 31, 2020 | -21.40 Mn |
| Jun 30, 2019 | -30.76 Mn |
| Jun 30, 2019 | -30.76 Mn |
| Mar 31, 2019 | -19.19 Mn |
| Mar 31, 2019 | -19.19 Mn |
| Sep 30, 2018 | -31.54 Mn |
| Sep 30, 2018 | -31.54 Mn |
| Jun 30, 2018 | -8.92 Mn |
| Jun 30, 2018 | -8.92 Mn |
| Mar 31, 2018 | -8.13 Mn |
| Mar 31, 2018 | -8.13 Mn |
| Dec 31, 2017 | -8.80 Mn |
| Dec 31, 2017 | -8.80 Mn |